Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki 12622, Giza, Egypt.
Stem Cell Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Giza, Egypt.
Inflammopharmacology. 2024 Jun;32(3):1961-1982. doi: 10.1007/s10787-024-01469-0. Epub 2024 Apr 23.
Gastric ulcer (GU) is one of the most common diseases of the upper gastrointestinal tract that affects millions of people worldwide. This study aimed to investigate the possible alleviating effect of a combined treatment of pantoprazole (PANTO) and adipose tissue-derived mesenchymal stem cells (ADSCs) in comparison with each treatment alone on the healing process of the experimentally induced GU in rats, and to uncover the involved pathways. Rats were divided into five groups: (1) Control, (2) GU, (3) PANTO, (4) ADSCs and (5) ADSCs + PANTO. Markers of oxidative stress, inflammation and apoptosis were assessed. The current data indicated that PANTO-, ADSCs- and ADSCs + PANTO-treated groups showed significant drop (p < 0.05) in serum advanced oxidation protein products (AOPPs) and advanced glycation end products (AGEPs) along with significant elevation (p < 0.05) in serum TAC versus the untreated GU group. Moreover, the treated groups (PANTO, ADSCs and ADSCs + PANTO) displayed significant down-regulation (p < 0.05) in gastric nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), tumor necrosis factor alpha (TNF-α), cyclooxygenase-2 (COX-2), intercellular adhesion molecule-1 (ICAM-1), matrix metallopeptidase 9 (MMP-9) and caspase-3 along with significant up-regulation (p < 0.05) in vascular endothelial growth factor (VEGF) and peroxisome proliferator-activated receptor gamma (PPARγ) genes expression compared to the untreated GU group. Immunohistochemical examination of gastric tissue for transforming growth factor β1 (TGF-β1), epidermal growth factor (EGF) and proliferating cell nuclear antigen (PCNA) showed moderate to mild and weak immune reactions, respectively in the PANTO-, ADSCs- and ADSCs + PANTO-treated rat. Histopathological investigation of gastric tissue revealed moderate to slight histopathological alterations and almost normal histological features of the epithelial cells, gastric mucosal layer, muscularis mucosa and submucosa in PANTO-, ADSCs- and ADSCs + PANTO-treated rats, respectively. Conclusively, the co-treatment with ADSCs and PANTO evidenced sententious physiological protection against GU by suppressing oxidative stress, inhibiting inflammation and reducing apoptosis with consequent acceleration of gastric tissue healing process.
胃溃疡(GU)是全球数百万人患有的最常见的上消化道疾病之一。本研究旨在探讨泮托拉唑(PANTO)和脂肪组织来源的间充质干细胞(ADSCs)联合治疗与单独治疗相比对实验性诱导的大鼠 GU 愈合过程的可能缓解作用,并揭示相关途径。大鼠分为五组:(1)对照组,(2)GU 组,(3)PANTO 组,(4)ADSCs 组和(5)ADSCs+PANTO 组。评估氧化应激、炎症和细胞凋亡标志物。目前的数据表明,与未治疗的 GU 组相比,PANTO、ADSCs 和 ADSCs+PANTO 治疗组的血清晚期氧化蛋白产物(AOPPs)和晚期糖基化终产物(AGEPs)显著下降(p<0.05),而血清总抗氧化能力(TAC)显著升高(p<0.05)。此外,治疗组(PANTO、ADSCs 和 ADSCs+PANTO)的核因子κB(NF-κB)、肿瘤坏死因子α(TNF-α)、环氧化酶-2(COX-2)、细胞间黏附分子-1(ICAM-1)、基质金属蛋白酶 9(MMP-9)和半胱天冬酶-3 的胃核基因表达显著下调(p<0.05),而血管内皮生长因子(VEGF)和过氧化物酶体增殖物激活受体γ(PPARγ)基因表达显著上调(p<0.05)与未治疗的 GU 组相比。胃组织转化生长因子β1(TGF-β1)、表皮生长因子(EGF)和增殖细胞核抗原(PCNA)的免疫组织化学检查显示,PANTO、ADSCs 和 ADSCs+PANTO 治疗大鼠的免疫反应分别为中度至轻度和弱。胃组织的组织病理学检查显示,PANTO、ADSCs 和 ADSCs+PANTO 治疗大鼠的胃组织分别有中度至轻度的组织病理学改变和上皮细胞、胃黏膜层、黏膜肌层和黏膜下层的几乎正常组织学特征。总之,ADSCs 和 PANTO 的联合治疗通过抑制氧化应激、抑制炎症和减少细胞凋亡,对 GU 具有显著的生理保护作用,从而加速胃组织的愈合过程。